Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10105 - 10112 of 12008 results

Department of Justice Criminal Division Will Increase its Review of False Claims Act Cases for Criminal Prosecution
September 19, 2014| Blog| Viewpoint

Daddy Dearest?: Some Considerations Concerning Paid Parental Leave for Fathers in the United States
September 18, 2014| Blog| Viewpoint

Employment Law Summer Recap 2014: Part 4 of 11 - Chris Pratt and Unexpected Surprises in Hollywood and the World of California Employment Law
September 18, 2014| Blog| Viewpoint

ML Strategies Posts Weekly Health Care Update on September 15, 2014
September 18, 2014| Blog| Viewpoint

D.C. the Latest Jurisdiction to Ban the Box
September 17, 2014| Blog| Viewpoint

Employment Law Summer Recap 2014: Part 3 of 11 - The Decision 2.0: This Time, LeBron Leaves the Right Way; Will Your Employees?
September 17, 2014| Blog| Viewpoint

California Employers May Get Ill Over California’s New Mandatory Paid Sick Leave Law
September 17, 2014| Blog| Viewpoint

NIST Vetting Guidance Valuable for Health Care Organizations Seeking to Use Third-Party Apps
September 17, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|

Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|
